In-Series Transcatheter Aortic Valve Replacement-in-Transcatheter Aortic Valve Replacement: ACURATE neo Transcatheter Heart Valve Degeneration Successfully Managed with Myval, Avoiding Coronary Flow Obstruction-A Case Report

Joao Felipe Barros de Toledo; Pablo Tome Teixeirense; Wilson Guimaraes; Julio Motta; Marcos Rogerio Joaquim; Vinicius Odone; Juliana Mantovani; Raphael Alves; Luiz Antonio Gubolino

doi:10.1016/j.shj.2023.100181

In-Series Transcatheter Aortic Valve Replacement-in-Transcatheter Aortic Valve Replacement: ACURATE neo Transcatheter Heart Valve Degeneration Successfully Managed with Myval, Avoiding Coronary Flow Obstruction-A Case Report

Struct Heart. 2023 Apr 10;7(5):100181. doi: 10.1016/j.shj.2023.100181. eCollection 2023 Sep.

Authors

Joao Felipe Barros de Toledo¹, Pablo Tome Teixeirense¹, Wilson Guimaraes¹, Julio Motta¹, Marcos Rogerio Joaquim², Vinicius Odone², Juliana Mantovani², Raphael Alves³, Luiz Antonio Gubolino¹

Affiliations

¹ Department of Interventional Cardiology, Unimed Hospital, Rio Claro, Brazil.
² Department of Cardiac Surgery, Unimed Hospital, Rio Claro, Brazil.
³ Department of Echocardiography, Unimed Hospital, Rio Claro, Brazil.

Abstract

•Durability is vital for transcatheter aortic valve replacement in younger patients.•Aortic insufficiency is one of the features of structural valve degeneration.•Degenerated ACURATE neo can be treated with low implantation of an oversized Myval.

Keywords: ACURATE neo; Aortic insufficiency; Myval; Redo - TAVR; Structural valve degeneration; Transcatheter aortic valve replacement.